HomeOVID • NASDAQ
add
Ovid Therapeutics Inc
Previous close
$1.62
Day range
$1.63 - $1.75
Year range
$0.24 - $2.01
Market cap
118.92M USD
Avg Volume
1.67M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 132.00K | -23.70% |
Operating expense | 12.66M | -5.55% |
Net income | -12.16M | 13.19% |
Net profit margin | -9.21K | -13.77% |
Earnings per share | -0.17 | 15.00% |
EBITDA | -12.51M | 4.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.60M | -59.17% |
Total assets | 63.85M | -37.80% |
Total liabilities | 19.15M | -27.36% |
Total equity | 44.70M | — |
Shares outstanding | 71.21M | — |
Price to book | 2.57 | — |
Return on assets | -44.32% | — |
Return on capital | -48.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.16M | 13.19% |
Cash from operations | -12.87M | 14.23% |
Cash from investing | 5.05M | 1,630.48% |
Cash from financing | 15.00K | -60.53% |
Net change in cash | -7.80M | 46.83% |
Free cash flow | -8.33M | 1.90% |
About
Founded
2014
Website
Employees
23
